Activity Description
Ophthalmology practice continues to evolve rapidly with evidence-based shifts reshaping clinical decision-making across multiple subspecialties. This supplement addresses four areas of active transformation: the emergence of complement inhibitor therapy and multimodal imaging for geographic atrophy (GA); the role of ocular surface optimization as a prerequisite for successful cataract and refractive surgery outcomes; a paradigm shift toward interventional, procedure-first strategies in early-stage glaucoma management; and a personalized approach to refractive IOL selection that integrates patient lifestyle, ocular biology, and lens technology. Each section of the supplement is authored by subspecialty experts and presents current evidence alongside practical frameworks designed to support immediate application in clinical practice. Together, the four sections of this supplement address the full continuum of patient care, from early detection and diagnosis through treatment selection, surgical planning, and long-term management and emphasize individualized, patient-centered approaches that improve outcomes and quality of life.

The Fundingsland Group is accredited by the ACCME to provide continuing medical education for physicians.
Release Date: 04-30-2026
Expiration Date: 04-30-2027
Target Audience
This accredited educational activity is designed for ophthalmologists.
Grant Support Statement
This activity is supported by an unrestricted educational grants from AbbVie, Alcon, Apellis Pharmaceuticals, Carl Zeiss Meditec, Harrow, Johnson & Johnson Vision, Sun Pharma, Tarsus, Thea, and Viatris.
Faculty














